Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen
NCT04680104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2020-12-22
Summary
Prospective observational study comparing calcium and sodium levofolinate in combination with 5FU/or in FOLFIRI regimen on patients affected by gastrointestinal cancer (any site of disease along with gastrointestinal tract) who have been prescribed FOLFIRI in standard clinical practice.
Conditions
- Gastrointestinal Cancer
- CALCIUM LEVOFOLINATO (Ca-lev)
- SODIUM LEVOFOLINATO (Na-lev)
Sponsors & Collaborators
-
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
lead OTHER
Principal Investigators
-
Alessandro Passardi, MD · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-03
- Primary Completion
- 2019-08-06
- Completion
- 2019-08-06
More Related Trials
-
A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
NCT06048146 ·Status: COMPLETED ·Phase: NA
-
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
NCT00976768 ·Status: COMPLETED ·Phase: PHASE2
-
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
NCT00537121 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
NCT00008281 ·Status: UNKNOWN ·Phase: PHASE3
-
ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line
NCT02624895 ·Status: COMPLETED
-
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00004885 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
NCT00006468 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
NCT02414009 ·Status: COMPLETED ·Phase: PHASE2
-
FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
NCT02935764 ·Status: UNKNOWN ·Phase: PHASE3
-
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies
NCT03043547 ·Status: COMPLETED ·Phase: PHASE2
-
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
NCT02605044 ·Status: TERMINATED ·Phase: PHASE3
-
Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma
NCT00183911 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
NCT00507091 ·Status: COMPLETED ·Phase: PHASE1
-
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
NCT01643499 ·Status: COMPLETED ·Phase: PHASE1
-
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
NCT06501989 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
NCT00006115 ·Status: UNKNOWN ·Phase: PHASE2
-
FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer
NCT05018182 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer
NCT00001428 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function
NCT00094965 ·Status: COMPLETED ·Phase: PHASE2
-
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
NCT01515787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status
NCT04252456 ·Status: UNKNOWN ·Phase: NA
-
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies
NCT00300027 ·Status: TERMINATED ·Phase: PHASE1
-
Colon Neoadjuvant FOLFOXIRI Study
NCT01941641 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
NCT00005607 ·Status: UNKNOWN ·Phase: PHASE2
-
FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)
NCT01138904 ·Status: COMPLETED ·Phase: PHASE2